Tianjin Medical University Cancer Institute and Hospital: all 490 studies

Page 5 of 5. Open to participants first (289), then studies with results posted, then the rest; newest registration first within each.

• Radiomics of Immunotherapeutics Response Evaluation and PredictionCompletedNCT04079283
• Phase 2 Study of Pyrotinib in Previously Treated Patients With NSCLC Having EGFR or ERBB2 Exon 20 Insertion MutationStatus unknownNCT04063462Phase 2
• Study of Anlotinib Combined With Osimertinib as Second-line Treatment in Stage IIIb-IV NSCLC With Confirmed EGFRm and T790MStatus unknownNCT04029350Phase 2
• Methods of Computed Tomography Screening and Management of Lung CancerStatus unknownNCT03992833Not applicable
• Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLCStatus unknownNCT03987867Phase 1
• Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell CarcinomaStatus unknownNCT03987698Phase 2
• Pegylated Liposomal Doxorubicin or Epirubicin in Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer.CompletedNCT03983096
• Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Advanced Lung CancerStatus unknownNCT03944980Phase 3
• Sintilimab Combined With Metformin in First-Line Chemotherapy Refractory Advanced NSCLC PatientsStatus unknownNCT03874000Phase 2
• The Technical Operations And Standard Clinical Application Protocol of CBBCT in Diagnostic Process of Breast CancerCompletedNCT03861221Not applicable
• The MDA Test to Differentiate of Benign and Malignant Pulmonary NodulesStatus unknownNCT03790735
• Adjuvant Chemotherapy for Biliary Tract Cancer After Curative ResectionStatus unknownNCT03779035Phase 3
• A Efficacy and Safety Study of Composite Gel Containing Black Raspberry Extract in Removing HPV From Patients With Cervical Intraepithelial Neoplasia(CIN) After Cervical ConizationStatus unknownNCT03745846Phase 2
• Effect of Radiation and Its Timing on Breast Reconstruction in Chinese PatientsStatus unknownNCT03743324
• Application of Intra-operative Prophylactic Antibiotics/Antiseptics in Chinese Breast Reconstruction PatientsStatus unknownNCT03742908Not applicable
• Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLCCompletedNCT03736837Phase 2
• A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal CancerStatus unknownNCT03708042Phase 3
• Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCCStatus unknownNCT03671265Not applicable
• Comprehensive Analysis of Gene Mutation Profile in Chinese NSCLC Patients by Next-generation SequencingCompletedNCT03609918
• The Criteria for Lymph Node Sorting for Pathological Examination in Gastric CancerStatus unknownNCT03478449Not applicable
• Study of Apatinib Combined With TACE in Advance Hepatocellular CarcinomaStatus unknownNCT03398122Not applicable
• XELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRCStatus unknownNCT03389659Phase 3
• Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESCStatus unknownNCT03366883Phase 3
• Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast CancerStatus unknownNCT03359694Phase 3
• Clinical Study of Neoadjuvant Therapy With Apatinib and Paclitaxel in Local Advanced Triple-negative Breast CancerStatus unknownNCT03348098Phase 2
• An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and GastricStatus unknownNCT03285906Phase 2/3
• Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic CancerStatus unknownNCT03236883Phase 1
• Combination of Radiotherapy and SHR-1210 to Treat Patients With ESCCCompletedNCT03222440Not applicable
• Irinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal CancerStatus unknownNCT03175016Phase 2/3
• Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid CarcinomaStatus unknownNCT03167385Phase 2
• Mesylate Apatinib for Stage Ⅳ STS After Failure of ChemotherapyStatus unknownNCT03121846Phase 2
• Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue SarcomaCompletedNCT03121833Phase 2
• The Exploratory Study of Electroacupuncture in the Treatment of Peripheral Neuropathy Induced by Platinum Based Chemotherapy DrugsStatus unknownNCT03048591Not applicable
• Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)Status unknownNCT03046979Phase 2
• Evaluation of Pcv-aCO2 in the Fluid Treatment of Abdominal Tumor Patients After SurgeryStatus unknownNCT02977429Not applicable
• A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal CancerStatus unknownNCT02959385Phase 2
• Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune DiseasesWithdrawnNCT02948855
• Effect of Different Anesthetics on the Change of Alarmins in Lung Cancer Patients Receiving Pulmonary LobectomyStatus unknownNCT02916147Not applicable
• A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic CancerStatus unknownNCT02863367Phase 2
• Retrospective Analysis of Effectiveness and Safety Profile of Anastrozole and Letrozole in HR+ Breast Cancer PatientsStatus unknownNCT02812277
• Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung CancerStatus unknownNCT02780778Phase 2/3
• A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant ChemotherapyStatus unknownNCT02776527Phase 4
• A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients.Status unknownNCT02774200Phase 2
• PERCIST Criteria for Response Evaluation With Solid TumorsStatus unknownNCT02765620
• Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal CancerStatus unknownNCT02762474Phase 1/2
• Efficacy and Optimal Dose Selection of Intranasal Dexmedetomidine During Breast Lumpectomy Under Local AnaesthesiaCompletedNCT02675049Phase 2
• Metformin Plus Sorafenib for Advanced HCCStatus unknownNCT02672488Phase 2
• Endocrine Therapy With or Without Cryoablation for Stage IV Prostate CancerStatus unknownNCT02615223Not applicable
• Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate CancerStatus unknownNCT02605226Not applicable
• Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLCCompletedNCT02497118Phase 4
• Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal CancerCompletedNCT02486198Phase 3
• Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnifeStatus unknownNCT02363218Phase 2
• Clinical Trial on the Efficacy and Safety of Chining Decoction in the Treatment of Radiation StomatitisCompletedNCT02303197Phase 3
• A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric CancerStatus unknownNCT02272894
• Molecular Phenotype Changes and Personalized Treatment for CRPCStatus unknownNCT02208583Not applicable
• Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast CancerStatus unknownNCT02207361Phase 4
• Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast CancerStatus unknownNCT02207335Phase 3
• Effect Study of Tigecycline to Treat Severe Sepsis and Septic ShockStatus unknownNCT02191475Phase 2/3
• Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast CancerStatus unknownNCT02161315
• Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric CancerStatus unknownNCT02024438Phase 3
• Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in mCRCStatus unknownNCT02024412Phase 3
• the Effect of Chinese Herbs to Treat Thyroid Diseases With Different Iodine IntakeStatus unknownNCT01873014Phase 1/2
• Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial PneumoniaStatus unknownNCT01796717Phase 2/3
• A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular CarcinomaStatus unknownNCT01758679Phase 4
• A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX TherapyStatus unknownNCT01758666Not applicable
• Clinical Randomized Study of Concurrent Chemo-radiotherapy vs Radiotherapy Alone to Local-advanced Small Cell Lung Cancer (SCLC)Status unknownNCT01745445Phase 2
• Preoperative Biliary Drainage for the Lower Malignant Obstructive JaundiceStatus unknownNCT01744938Phase 3
• Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFRStatus unknownNCT01744925Phase 2
• Clinical Safety and Preliminary Efficacy of MAGE-A4 TCR Gene-Modified T Cells to Treat Malignant TumorsStatus unknownNCT01694472Phase 1
• Erlotinib in Post Radical Operation NSCLC Patients With EGFR MutationStatus unknownNCT01683175Phase 2
• Clinical Application of Breast Blood-oxygen Functional Imaging TechnologyStatus unknownNCT01678170
• Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as ChemotherapyStatus unknownNCT01660399Phase 2
• Clinical Safety and Preliminary Efficacy of AAV-DC-CTL Treatment in Stage IV Gastric CancerStatus unknownNCT01637805Phase 1
• Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 DiabetesStatus unknownNCT01637350
• Vinorelbine Plus Capecitabine Versus Docetaxel Plus Capecitabine in Anthracycline-pretreated Women With Metastatic Breast CancerStatus unknownNCT01635465
• The Diagnostic Technology Applied Research of CDK5RAP2 in Breast CancerStatus unknownNCT01634984
• External Drainage Versus Internal Drainage of Pancreatic Duct With a Stent After Pancreaticoduodenectomy (EDIDPD)Status unknownNCT01634971Phase 2
• Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung CancerCompletedNCT01631357Phase 2/3
• Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer PatientsStatus unknownNCT01618474Phase 2
• Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic CancerWithdrawnNCT01598584Phase 2/3
• Trial of Endostar Combined With CHOPT for T Cell LymphomaStatus unknownNCT01430013Phase 2
• Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas (TACE-KMG)Status unknownNCT01393197Not applicable
• Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular CarinomasStatus unknownNCT01393093Not applicable
• Nimotuzumab in Combination With Paclitaxel Liposome and Carboplatin (TP Regimen) for the Advanced NSCLC PatientsStatus unknownNCT01393080Not applicable
• GWAS Research of Lung Cancer in TianjinStatus unknownNCT01255059
• Impact of the Techniques for Intrathoracic Esophagogastric Anastomosis on Outcome in Ivor-Lewis OesophagectomyStatus unknownNCT01242124Phase 2/3
• Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC)CompletedNCT01099124Not applicable
• Clinical Trial of Bile Etiology ,Proteomics and Metabonomics of Malignant Biliary ObstructionStatus unknownNCT01073514
• Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC)SuspendedNCT00986284Phase 2
• Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung CancerStatus unknownNCT00973310Phase 2

← Tianjin Medical University Cancer Institute and Hospital overview and focus areas